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Theaimofthisstudywastoclarifythefunctionofamelogenin,themajorproteinofenamelmatrixderivative,ontheproliferation,
diﬀerentiation, and mineralization of cultured rat bone marrow stem cells (BMSCs), toward the establishment of future bone
regenerative therapies. No diﬀerences in the morphology of BMSCs or in cell numbers were found between amelogenin addition
and additive-free groups. The promotion of ALPase activity and the formation of mineralized nodules were detected at an early
stage in amelogenin addition group. In quantitative real-time RT-PCR, mRNA expression of osteopontin, osteonectin, and type I
collagen was promoted for 0.5 hours and 24 hours by addition of amelogenin. The mRNA expression of osteocalcin and DMP-1
was also stimulated for 24 hours and 0.5 hours, respectively, in amelogenin addition group. These ﬁndings clearly indicate that
amelogenin promoted the diﬀerentiation and mineralization of rat BMSCs but did not aﬀect cell proliferation or cell morphology.
1.Introduction
In recent years, with advances in regenerative medicine, the
possibility of regenerating mandibular bone, alveolar bone,
and dentin has attracted attention. For the induction of
alveolar bone formation, enamel matrix derivative (EMD)
has been applied in the ﬁeld of periodontology [1–3].
Hammarstr¨ om reported that, when mesenchymal cells of
the dental follicle were exposed to EMD, a noncellular hard
tissue matrix formed at the enamel surface and that the
application of porcine EMD in experimental cavities in
the roots of incisors of monkeys induced the formation of
acellular cementum that was well attached to the dentin
[4]. It was reported that porcine EMD was used in patients
with severe periodontitis to induce cementogenesis as EMD
induces a process that seems to mimic normal odontogenesis
[1–3]. Recently, some studies showed that EMD enhances
the expression of tissue-speciﬁc maturation markers, such
as ALPase activity, collagen, and osteocalcin within osseous
tissues [5–7]. Moreover, recent studies applied EMD to vital
pulp therapy in endodontics [8–10]. A study comparing
the eﬀect of EMD with calcium hydroxide as a direct pulp
capping agent in pigs [11] demonstrated a signiﬁcantly more
pronounced formation of secondary dentine in teeth treated
with EMD.
The major constituent of EMD is amelogenin, a family
member of hydrophobic proteins derived from a single
gene by alternative splicing and controlled postsecretory
processing [12]. It is the major organic component in the
enamel matrix of developing teeth and plays an important
role in enamel biomineralization [13, 14]. It is speciﬁcally
detectedinameloblasts,butseveralstudieshavealsodetected
it in odontoblasts and might induce the diﬀerentiation and
maturation of odontoblasts [15–17]. The amelogenin is also
known to self-assemble into supramolecular aggregates that
form an insoluble extracellular matrix [18] with high aﬃnity
for hydroxyapatite and collagens [19]. Many recent studies
reported that amelogenin interacts directly with cell types2 The Scientiﬁc World Journal
other than cementoblasts [20–22], suggesting that it plays a
more direct role in the growth of mesenchymal tissues.
Therefore, we gave importance to the functions of
amelogenin, which is a major component of EMD, for the
potential of regeneration of hard tissues such as bone and
dentin clinically. In the present study, we investigated the
eﬀects of amelogenin on proliferation, diﬀerentiation, and
mineralization in rat bone marrow mesenchymal stem cells
(BMSCs) in vitro.
We added amelogenin to cultured rat BMSCs and exam-
inedthechangesofcellmorphologyandcellnumber,ALPase
activity, and the formation of mineralized nodules. Then,
mRNA expression of bone-related proteins osteopontin,
osteonectin, osteocalcin, type I collagen, and dentin matrix
protein-1 (DMP-1) in BMSCs was detected by using the
quantitative real-time RT-PCR method.
2.MaterialsandMethods
2.1. Amelogenin. We purchased amelogenin (Hokudo, Sap-
poro, Japan) having a molecular weight of 25kDa and
puriﬁed mainly from enamel of bovine immature tooth.
It was adjusted to concentration of 1mg/mL Dulbecco’s
phosphate-buﬀered saline (PBS) after the purchase, and was
stored at −80◦C until use.
2.2. Bone Marrow Mesenchymal Stem Cell (BMSC) Isolation
and Culture. All protocols were performed in accordance
with the guidelines of the Animal Care Committee of the
Health Sciences University of Hokkaido. BMSC isolation and
culture were performed according to previously described
methods [23]. In brief, we harvested bone marrow from
7-week-old male Fischer 344 rats (Hokudo) by ﬂushing
their femoral cavities with Dulbecco’s PBS. BMSCs were
cultured in α-minimal essential medium (α-MEM; Invitro-
gen, Carlsbad, Calif, USA), 15% fetal bovine serum (FBS,
MultiSer Trace Scientiﬁc, Melbourne, Australia), 100U/mL
penicillin (Invitrogen), and 100μg/mL streptomycin (Invit-
rogen). Nonadherent hematopoietic cells were removed, and
the medium was replaced. The medium was refreshed every
3 days. The adherent, spindle-shaped BMSC population
expanded to >5 × 107 cells within 3–5 passages after the cells
were ﬁrst plated.
2.3. Cell Morphology and Proliferation. We compared the
morphology and proliferative activity of BMSCs cultured
in α-MEM and 15% FBS with or without 100ng/mL
amelogenin. In brief, cells (5 × 104 cells/well) were cultured
in 24-well plates with culture medium, and changes of cell
morphology were observed with phase-contrast microscopy
at 2, 5, 8, 11, and 14 days after the addition of amelogenin.
Then, cells were harvested and counted with a hemocytome-
ter.
2.4. Cell Diﬀerentiation. Mineralized nodules were detected
by Von Kossa staining [24]. Brieﬂy, cells were ﬁxed with
99.5%ethanol(Wako,Tokyo,Japan)for10min,washedwith
distilled water, and then treated with 5% AgNO3 for 15min,
washed again with distilled water, and treated with 5%
sodium thiosulfate for 5min. The specimens were examined
under a light microscope.
ALPase activity is considered essential for biomineral-
ization. The cells were washed three times with PBS and
sonicated with 1mL of 0.1-M Tris buﬀer (pH 7.2) containing
0.1%TritonX-100(SigmaChemical,St.Louis,Mo,USA)for
30sec on ice. Cellular ALPase activity was assayed using p-
nitrophenyl phosphate as a substrate. The enzyme activity
is expressed as micromoles of p-nitrophenyl produced per
minute per milligram of protein. The protein concentration
wasdeterminedusingtheBio-RadDCproteinassaykit(Bio-
Rad Laboratories, Hercules, Calif, USA) with albumin as the
standard.
2.5. Quantitative Real-Time RT-PCR. The cells (1 ×
105 cells/dish) were seeded in 60-mm culture dishes. After
reaching conﬂuence, amelogenin (0, 10, 100, or 1000ng/mL)
was added to the cells with serum-free medium. After
30min and 24h, the cells were collected with TRIzol reagent
(Invitrogen). Total cellular RNA was reverse-transcribed
using SUPERSCRIPT II (Invitrogen) to synthesize cDNA.
PCR was then carried out to measure the mRNA expression
of osteopontin, osteonectin, osteocalcin, type I collagen,
and dentin matrix protein-1 (DMP-1). The housekeeping
gene glyceraldehyde-6-phosphate dehydrogenase (GAPDH)
was also measured as a control. Their primer sequences are
shown in Table 1.
Quantitative real-time PCR assay was performed with
a LightCycler using the double-stranded DNA dye SYBR
Green I (Roche Diagnostics, Mannheim, Germany) [25,
26]. Quantiﬁcation was performed by comparing the levels
obtained to standardized samples. The PCR conditions
used in the LightCycler are shown in Table 2.T h eﬁ n a l
concentration of MgCl2 was 3mM. A standard curve was
constructedbyreﬁningPCRproductsusingaHighPurePCR
ProductPuriﬁcationKit(RocheDiagnostics)followedby10-
fold dilutions. Melting curve analysis was also performed
after the PCR ampliﬁcation to conﬁrm the absence of the
primerdimerinthePCRproducts.Inaddition,theﬁnalPCR
product on 2% agarose gels migrated as a single band with a
sequence identical to that of each protein.
2.6. Statistical Analysis. The cell counts and ALPase activities
were analyzed by Student’s t-test and expressed as means ±
SD. The gene expressions were analyzed by one-way analysis
of variance with Tukey’s multiple comparison test. Diﬀer-
ences at P<0.05 were considered statistically signiﬁcant.
3. Results
3.1. Cell Morphology, Proliferation, Diﬀerentiation, and Min-
eralization. BMSCs with and without exposure to amel-
ogenin were ﬁbroblast-shaped initially and were cubic-
shaped after reaching conﬂuence on day 8. In the group
with amelogenin, mineralized nodules were detected by Von
Kossa staining at day 11 (Figure 1). In the group without
amelogenin, mineralized nodules were observed after day 15
(data not shown).The Scientiﬁc World Journal 3
Table 1: Primer sequences for target cDNAs.
Target cDNA Primer sequence
GAPDH (200bp) Upstream: 5 -TCC ATG ACA ACT TTG GTA TCG-3 
Downstream: 5 -ATG AGT CCT TCC ACG ATA CCA-3 
Osteopontin (220bp) Upstream: 5 -CTC AGA GGA GAA GGC GCA TTG-3 
Downstream: 5 -TCT CTG CAT GGT CTC CGT CGT -3 
Osteonectin (225bp) Upstream: 5 -GTC CTG GTC ACC TTG TAC GAG-3 
Downstream: 5 -GGG ACA GGT ACC CAT CAA TCG -3 
Osteocalcin (175bp) Upstream: 5 -AAG GTG GTG AAT AGA CTC CG-3 
Downstream: 5 -AAA CGG TGG TGC CAT AGA TG-3 
Type I collagen (181bp) Upstream: 5 -TGC CGT GAC CTC AAG ATG T-3 
Downstream: 5 -TGG GGT TTG GGC TGA TGT A-3 
DMP-1 (163bp) Upstream: 5 -AGC ATT CCT CTA ATC CAG TT-3 
Downstream: 5 -CTG ATC TAA ACA AGT GCC AT-3 
Table 2: Conditions of quantitative PCR using LightCycler.
Target cDNA PCR conditions
GAPDH 95◦C1 0m i n (35cycles)
95◦C1 0s e c6 2 ◦C5s e c7 2 ◦C1 5s e c 67◦C1 0s e c 4 0 ◦C6 0s e c
Osteopontin 95◦C1 0m i n (30cycles)
95◦C1 0s e c6 3 ◦C5s e c7 2 ◦C1 5s e c 78◦C1 0s e c 4 0 ◦C3 0s e c
Osteonectin 95◦C1 0m i n (30cycles)
95◦C1 0s e c6 1 ◦C5s e c7 2 ◦C1 5s e c 66◦C1 0s e c 4 0 ◦C3 0s e c
Osteocalcin 95◦C1 0m i n (35cycles)
95◦C1 0s e c6 2 ◦C1 0s e c7 2 ◦C0 5s e c 70◦C1 5s e c 4 0 ◦C3 0s e c
Type I collagen 95◦C1 0m i n (40cycles)
95◦C1 0s e c6 2 ◦C1 0s e c7 2 ◦C0 7s e c 70◦C1 5s e c 4 0 ◦C3 0s e c
DMP-1 95◦C1 0m i n (40cycles)
95◦C1 0s e c6 2 ◦C1 0s e c7 2 ◦C0 7s e c 70◦C1 5s e c 4 0 ◦C3 0s e c
The number of cells did not signiﬁcantly diﬀer bet-
ween the groups throughout the experimental period
(Figure 2(a)). On the other hand, ALPase activity in the
group with amelogenin was signiﬁcantly higher than that in
the group without amelogenin (Figure 2(b)).
3.2. Bone-Related mRNA Expression. In quantitative real-
time RT-PCR, mRNA expression of osteopontin was pro-
moted signiﬁcantly by addition of 100 and 1,000ng/mL
of amelogenin for 0.5 hours (Figure 3). As for osteonectin
and type I collagen mRNA, the expression was signiﬁcantly
accelerated by the addition of 10, 100, and 1,000ng/mL
of amelogenin for 0.5 hours (Figures 3 and 4). Also, the
additionof100ng/mLofamelogeninfor24hoursstimulated
the expression of osteopontin, osteonectin, and type I
collagen mRNA (Figures 3 and 4). Amelogenin addition at
a concentration of 100ng/mL for 24 hours signiﬁcantly pro-
moted osteocalcin mRNA expression, although the addition
of 10, 100, and 1,000ng/mL of amelogenin for 0.5 hours did
not (Figure 4).
Moreover, DMP-1 mRNA expression was increased after
the addition of amelogenin at a concentration of 100 and
1,000ng/mL for 0.5 hours, but it was below the detection
threshold after 24 hours (Figure 5).
4. Discussion
Currently, ectodermal tooth enamel proteins, in the form
of a commercial preparation of porcine fetal enamel matrix
derivative (EMD), are frequently used in surgical procedures
to induce mesenchymal cell diﬀerentiation for cementogene-
sis and periodontal ligament regeneration in patients having
severe periodontitis [3]. To date, a wide range of in vitro and
in vivo experimental studies have demonstrated that EMD
stimulates the growth of multiple mesenchymal cell types
including ﬁbroblasts, cementoblasts, and osteoblasts [4–7].
The study also showed that EMD enhances the expression of
tissue-speciﬁc maturation markers, such as ALPase activity,
type I collagen, osteopontin, and osteocalcin in osteoblastic
celllines [6,27,28].Furthermore,EMDhasbeenreported to
induce the formation of mineralized nodules in osteoblastic
cell culture [29]. However, it was previously demonstrated
that EMD contains TGF-β1o raT G F - β-like substance and
that EMD rapidly translocates smad2, which is an eﬀector
of the TGF-β signaling pathway, into the nucleus [30].
Therefore, in the present study, we examined the function
of the major (>95%) constituent of EMD, amelogenin, in an
in vitro experimental system.
We found that 100ng/mL of amelogenin aﬀected neither
the proliferation of BMSCs nor the cell morphology. On the4 The Scientiﬁc World Journal
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Figure 1: Eﬀects of 100ng/mL of amelogenin on morphology and mineralization of rat bone marrow mesenchymal stem cells. (a) Phase-
contrast features of rat bone marrow mesenchymal stem cells at 2, 8, and 11 days of culture with and without amelogenin (original



































































Figure 2: Eﬀects of 100ng/mL of amelogenin on proliferation and diﬀerentiation of at bone marrow mesenchymal stem cells. (a) Time-
course changes in numbers of cells cultured with and without amelogenin. (b) Time-course changes in ALPase activity of cells cultured with
and without amelogenin. Data represent means ± SD in three samples in three separate experiments. Signiﬁcantly diﬀerent from control
















































































Figure 3: Graph of osteopontin (a) and osteonectin (b) copy
number determined using LightCycler. Data represent means ± SD
in ﬁve samples in three separate experiments. Signiﬁcantly diﬀerent
from control values (∗P<0.05).
other hand, it stimulated ALPase activity in the cells and
the formation of mineralized nodules earlier. The increase in
the activity levels of ALP, an intracellular enzyme necessary
for mineralization, is considered to be an early marker of
cells oriented towards osteogenic production [31]. Matrix-
mediated mineral deposition in osteoblasts or osteoblast-
like cells was demonstrated by Von Kossa staining. This
histological staining is based on the capacity of silver nitrate
to speciﬁcally react with phosphate in the presence of
acidic material, and its positive appearance is considered
an expression of the mineralization of bone matrix [32].
Therefore, in the present study, amelogenin functioned as
ad i ﬀerentiation-calciﬁcation factor to BMSCs rather than a












































































Figure 4: Graph of osteocalcin (a) and type I collagen (b) copy
number determined using LightCycler. Data represent means ± SD
in ﬁve samples in three separate experiments. Signiﬁcantly diﬀerent
from control values (∗P<0.05).
on titanium on ALPase activity has been reported in human
fetal preosteoblasts [33].
We used quantitative PCR to investigate the gene expres-
sion of a diﬀerentiation marker of osteoblasts in BMSCs in
the presence of amelogenin. The commitment of BMSCs to
osteogenic diﬀerentiation was demonstrated by the expres-
sion of osteopontin, osteonectin, osteocalcin, type I collagen,
andDMP-1.Theseproteinsareconsideredaslineage-speciﬁc
markers of osteoblastic diﬀerentiation [34]. Osteopontin
is a phosphoprotein member of the SIBLING family that
possesses several calcium-binding domains and is associated
with cell attachment, proliferation, and mineralization of
extracellular matrix into bone, synthesized by bone-forming
































Figure 5: Graph of DMP-1 copy number determined using
LightCycler. Data represent means ± SD in ﬁve samples in three
separate experiments. (—) means not detectable. Signiﬁcantly
diﬀerent from control values (∗P<0.05).
calcium- and collagen-binding extracellular matrix glyco-
protein abundantly expressed in bone undergoing active
remodeling [36]. Osteocalcin binds with high aﬃnity to
hydroxyapatite crystals, the key mineral component of bone,
andregulatesbonecrystalgrowth[37];itisthelatestsecreted
extracellular matrix protein to be identiﬁed. Type I collagen
is the major organic component of bone matrix produced
by osteoblasts. It functions as a scaﬀold of mineralization in
bone. In the present study, we found that the expressions
of osteopontin mRNA was accelerated by addition of 100
a n d1 , 0 0 0 n g / m Lo fa m e l o g e n i nf o r0 . 5h o u r sa sw e l la s
by the addition of 100ng/mL of amelogenin for 24 hours,
and that as for osteonectin and type I collagen mRNA
expression was promoted by addition of every amelogenin
concentration tested (10,100 and 1,000ng/mL) for 0.5 hours
as well as by the addition of 100ng/mL of amelogenin for
24 hours. On the other hand, stimulation of osteocalcin
mRNA expression by 100ng/mL of amelogenin required 24
hours. These results are consistent with the reports described
above. Moreover, our previous study demonstrated that
amelogenin enhanced mRNA expressions of BMP-2 and
BMP-4 in rat BMSCs [38]. Chen et al. reported that BMP-
2 enhances BMP-3, BMP-4, type I collagen, osteopontin, and
osteocalcin mRNA expression and promotes ALPase activity
as a diﬀerentiation marker in rat calvarium osteoblasts [39].
Thus, diﬀerentiative induction from BMSCs into osteoblasts
by the addition of amelogenin is thought to be mediated by
BMP expression.
DMP-1, an acidic phosphorylated extracellular matrix
protein [40], is expressed in odontoblasts that secrete
matrix proteins to form dentin. In vitro studies suggest
that overexpression of Dmp-1 induces the diﬀerentiation of
mesenchymal cells to odontoblast-like cells and enhances
mineralization [41] and that DMP-1 can bind to Ca2+
and initiate mineral deposition in vitro [42]. Moreover,
DMP-1 is shown to be a bone matrix protein expressed in
osteoblasts and osteocytes and is assumed to play a role
in bone mineral homeostasis due to its high calcium ion-
binding capacity [43]. As shown in a recent report that
a lack of DMP-1 gave rise to rickets or osteomalacia in
mice [44], a possible role of osteocytes mediating DMP-1
appears to be the local regulation of mineralization. Thus,
it is not speciﬁc in dentin. In the present study, DMP-1
mRNA expression was increased by amelogenin addition
at concentrations of 100 and 1,000ng/mL for 0.5 hours.
However, the level of DMP-1 mRNA expression was lower
than those of other genes. Especially, it was below the
detection threshold after 24 hours. Thus, the induction may
have been caused by osteoblastic diﬀerentiation rather than
odontoblastic diﬀerentiation.
Our results clearly showed that amelogenin promoted
diﬀerentiation and mineralization of cultured rat BMSCs
but did not aﬀect cell proliferation or cell morphology.
Further studies are necessary to elucidate the mechanism of
the induction of osteoblastic diﬀerentiation of BMSCs by
amelogenin and also conﬁrm the diﬀerentiation in animal
models. In vivo experiments will be required in order to
clarify the signiﬁcance of amelogenin-induced hard-tissue
regeneration.
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